Liposomal gD Ectodomain (gD(1-306)) Vaccine Protects Against HSV2 Genital or Rectal Infection of Female and Male Mice

Gelijkaardige items

• An HSV-2 nucleoside-modified mRNA genital herpes vaccine containing glycoproteins gC, gD, and gE protects mice against HSV-1 genital lesions and latent infection
  door: Egan, Kevin P., et al.
  Gepubliceerd in: (2020)
• Topical Herpes Simplex Virus 2 (HSV-2) Vaccination with Human Papillomavirus Vectors Expressing gB/gD Ectodomains Induces Genital-Tissue-Resident Memory CD8(+) T Cells and Reduces Genital Disease and Viral Shedding after HSV-2 Challenge
  door: Çuburu, Nicolas, et al.
  Gepubliceerd in: (2014)
• Tailoring Uptake Efficacy of HSV-1 gD Tailoring Uptake Efficacy of Hsv-1 GD Derived Carrier Peptides
  door: Bősze, Szilvia, et al.
  Gepubliceerd in: (2020)
• A Herpes Simplex Virus 2 (HSV-2) gD Mutant Impaired for Neural Tropism Is Superior to an HSV-2 gD Subunit Vaccine To Protect Animals from Challenge with HSV-2
  door: Wang, Kening, et al.
  Gepubliceerd in: (2015)
• Antibody to HSV gD peptide induced by vaccination does not protect against HSV-2 infection in HSV-2 seronegative women
  door: Gilbert, Peter B., et al.
  Gepubliceerd in: (2017)